136 related articles for article (PubMed ID: 26088443)
1. Detection of human parvovirus 4 viremia in the follow-up blood samples from seropositive individuals suggests the existence of persistent viral replication or reactivation of latent viral infection.
Chen MY; Hung CC; Lee KL
Virol J; 2015 Jun; 12():94. PubMed ID: 26088443
[TBL] [Abstract][Full Text] [Related]
2. Immunoglobulin G and M antibodies to human parvovirus 4 (PARV4) are frequently detected in patients with HIV-1 infection.
Yang SJ; Hung CC; Chang SY; Lee KL; Chen MY
J Clin Virol; 2011 May; 51(1):64-7. PubMed ID: 21353629
[TBL] [Abstract][Full Text] [Related]
3. Production of human parvovirus 4 VP2 virus-like particles in yeast and their evaluation as an antigen for detection of virus-specific antibodies in human serum.
Tamošiūnas PL; Simutis K; Kodzė I; Firantienė R; Emužytė R; Petraitytė-Burneikienė R; Zvirblienė A; Sasnauskas K
Intervirology; 2013; 56(5):271-7. PubMed ID: 23941824
[TBL] [Abstract][Full Text] [Related]
4. Occurrence of human bocaviruses and parvovirus 4 in solid tissues.
Norja P; Hedman L; Kantola K; Kemppainen K; Suvilehto J; Pitkäranta A; Aaltonen LM; Seppänen M; Hedman K; Söderlund-Venermo M
J Med Virol; 2012 Aug; 84(8):1267-73. PubMed ID: 22711355
[TBL] [Abstract][Full Text] [Related]
5. Absence of novel human parvovirus (PARV4) in Danish mothers and children.
von Linstow ML; Rosenfeldt V; Lindberg E; Jensen L; Hedman L; Li X; Väisänen E; Hedman K; Norja P
J Clin Virol; 2015 Apr; 65():23-5. PubMed ID: 25766982
[TBL] [Abstract][Full Text] [Related]
6. Testing UK blood donors for exposure to human parvovirus 4 using a time-resolved fluorescence immunoassay to screen sera and Western blot to confirm reactive samples.
Maple PA; Beard S; Parry RP; Brown KE
Transfusion; 2013 Oct; 53(10 Pt 2):2575-84. PubMed ID: 23721256
[TBL] [Abstract][Full Text] [Related]
7. Low Prevalence of Parvovirus 4 in HIV-infected Children in Denmark.
Rosenfeldt V; Norja P; Lindberg E; Jensen L; Hedman L; Väisänen E; Li X; Hedman K; von Linstow ML
Pediatr Infect Dis J; 2015 Jul; 34(7):761-2. PubMed ID: 25545184
[TBL] [Abstract][Full Text] [Related]
8. Recurrent high level parvovirus B19/genotype 2 viremia in a renal transplant recipient analyzed by real-time PCR for simultaneous detection of genotypes 1 to 3.
Liefeldt L; Plentz A; Klempa B; Kershaw O; Endres AS; Raab U; Neumayer HH; Meisel H; Modrow S
J Med Virol; 2005 Jan; 75(1):161-9. PubMed ID: 15543575
[TBL] [Abstract][Full Text] [Related]
9. Parvovirus PARV4 visualization and detection.
Tuke PW; Parry RP; Appleton H
J Gen Virol; 2010 Feb; 91(Pt 2):541-4. PubMed ID: 19846677
[TBL] [Abstract][Full Text] [Related]
10. First report of human parvovirus 4 detection in Iran.
Asiyabi S; Nejati A; Shoja Z; Shahmahmoodi S; Jalilvand S; Farahmand M; Gorzin AA; Najafi A; Haji Mollahoseini M; Marashi SM
J Med Virol; 2016 Aug; 88(8):1314-8. PubMed ID: 26812938
[TBL] [Abstract][Full Text] [Related]
11. Human parvovirus PARV4 DNA in tissues from adult individuals: a comparison with human parvovirus B19 (B19V).
Corcioli F; Zakrzewska K; Fanci R; De Giorgi V; Innocenti M; Rotellini M; Di Lollo S; Azzi A
Virol J; 2010 Oct; 7():272. PubMed ID: 20950445
[TBL] [Abstract][Full Text] [Related]
12. Persistence of novel human parvovirus PARV4 in liver tissue of adults.
Schneider B; Fryer JF; Reber U; Fischer HP; Tolba RH; Baylis SA; Eis-Hübinger AM
J Med Virol; 2008 Feb; 80(2):345-51. PubMed ID: 18098166
[TBL] [Abstract][Full Text] [Related]
13. High frequencies of exposure to the novel human parvovirus PARV4 in hemophiliacs and injection drug users, as detected by a serological assay for PARV4 antibodies.
Sharp CP; Lail A; Donfield S; Simmons R; Leen C; Klenerman P; Delwart E; Gomperts ED; Simmonds P
J Infect Dis; 2009 Oct; 200(7):1119-25. PubMed ID: 19691429
[TBL] [Abstract][Full Text] [Related]
14. Detection of PARV4, genotypes 1 and 2, in healthy and pathological clinical specimens.
Botto S; Bergallo M; Sidoti F; Terlizzi ME; Astegiano S; Ponti R; Costa C; Cavallo R
New Microbiol; 2009 Apr; 32(2):189-92. PubMed ID: 19579698
[TBL] [Abstract][Full Text] [Related]
15. Comparison of tissue distribution, persistence, and molecular epidemiology of parvovirus B19 and novel human parvoviruses PARV4 and human bocavirus.
Manning A; Willey SJ; Bell JE; Simmonds P
J Infect Dis; 2007 May; 195(9):1345-52. PubMed ID: 17397006
[TBL] [Abstract][Full Text] [Related]
16. Non-hydropic intrauterine fetal death more than 5 months after primary parvovirus B19 infection.
Nyman M; Skjöldebrand-Sparre L; Broliden K
J Perinat Med; 2005; 33(2):176-8. PubMed ID: 15843271
[TBL] [Abstract][Full Text] [Related]
17. Human parvovirus 4 prevalence among HTLV-1/2 infected individuals in Brazil.
Slavov SN; Otaguiri KK; Smid J; de Oliveira AC; Casseb J; Martinez EZ; Covas DT; Eis-Hübinger AM; Kashima S
J Med Virol; 2017 Apr; 89(4):748-752. PubMed ID: 27589576
[TBL] [Abstract][Full Text] [Related]
18. High frequency of parvovirus B19 DNA in bone marrow samples from rheumatic patients.
Lundqvist A; Isa A; Tolfvenstam T; Kvist G; Broliden K
J Clin Virol; 2005 May; 33(1):71-4. PubMed ID: 15797368
[TBL] [Abstract][Full Text] [Related]
19. Human Parvovirus 4: A harmless bystander or a pathogen of severe acute respiratory illness.
Prakash S; Shukla S; Ramakrishna V; Mishra H; Bhagat AK; Jain A
Int J Infect Dis; 2020 Jan; 90():21-25. PubMed ID: 31605808
[TBL] [Abstract][Full Text] [Related]
20. Frequency of human parvovirus 4 (PARV4) viremia among HBV-infected patients and healthy donors in Shiraz, Iran.
Amirahmadi F; Sarvari J; Hosseini SY; Pirbonyeh N; Gorzin AA
Turk J Med Sci; 2017 Jun; 47(3):868-873. PubMed ID: 28618736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
